CLEC4D and COVID-19: Samples with higher scores tended to have a higher probability of COVID-19, and significantly higher expressions of CLEC4D, DUSP13, and UNC5A were found in COVID-19 patients compared with those in healthy controls in GSE152641 (Figure 7A,C–E) and GSE171110 (Figure 8A,C–E).